{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:15Z","timestamp":1792068855836,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmc.2026.118819","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:28:19Z","timestamp":1790954899000},"page":"118819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the putative allosteric site J of cannabinoid receptor type 2 with peptide modulators: From mechanistic investigation to candidate identification"],"prefix":"10.1016","volume":"143","author":[{"given":"Xinyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118819_bb0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acs.chemrev.5b00411","article-title":"Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2 receptor agonists","volume":"116","author":"Aghazadeh Tabrizi","year":"2016","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2026.118819_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.02.035","article-title":"Neurochemical basis of cannabis addiction","volume":"181","author":"Maldonado","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2026.118819_bb0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871529X18666180206161457","article-title":"The endocannabinoid system and heart disease: the role of cannabinoid receptor type 2","volume":"18","author":"Fulmer","year":"2018","journal-title":"CHDDT"},{"key":"10.1016\/j.bmc.2026.118819_bb0020","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmc.2026.118819_bb0025","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55582","article-title":"Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain","volume":"9","author":"Caba\u00f1ero","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.bmc.2026.118819_bb0030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbi.2024.05.016","article-title":"Cannabidiol ameliorates PTSD-like symptoms by inhibiting neuroinflammation through its action on CB2 receptors in the brain of male mice","volume":"119","author":"Xie","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bmc.2026.118819_bb0035","first-page":"897","article-title":"Advances in the study of pharmacotherapy for addiction to naturally-derived psychoactive substances","volume":"23","author":"Xie","year":"2025","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.bmc.2026.118819_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/alz.093442","article-title":"Targeting cannabinoid type 2 receptors alters human tau levels in ex vivo brain slice cultures","volume":"20","author":"Joers","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bmc.2026.118819_bb0045","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.tips.2022.06.010","article-title":"Developing the cannabinoid receptor 2 (CB2) pharmacopoeia: past, present, and future","volume":"43","author":"Whiting","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2026.118819_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108022","article-title":"The development and therapeutic potential of classical and next-generation cannabinoid ligands","volume":"222","author":"Mu\u00f1oz-Canales","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2026.118819_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.tips.2017.05.010","article-title":"Applying structure-based drug design approaches to allosteric modulators of GPCRs","volume":"38","author":"Congreve","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2026.118819_bb0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/164_2025_771","article-title":"Biased allosteric modulation in GPCR drug discovery","volume":"290","author":"Zhou","year":"2026","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bmc.2026.118819_bb0065","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.tips.2025.10.008","article-title":"Elucidating biased signaling in class a GPCRs","volume":"46","author":"Xu","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2026.118819_bb0070","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.aaw8981","article-title":"Mechanism of \u03b22AR regulation by an intracellular positive allosteric modulator","volume":"364","author":"Liu","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bmc.2026.118819_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2019.12.011","article-title":"Antidepressant effects and mechanisms of group II mGlu receptor-specific negative allosteric modulators","volume":"105","author":"Potter","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.bmc.2026.118819_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-025-00788-y","article-title":"Structural basis for allosteric agonism of human \u03b17 nicotinic acetylcholine receptors","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Discov"},{"key":"10.1016\/j.bmc.2026.118819_bb0085","doi-asserted-by":"crossref","first-page":"408a","DOI":"10.1016\/j.bpj.2012.11.2278","article-title":"Rational design of neutral allosteric modulators of the CB1 receptor with improved receptor interactions and unique pharmacology","volume":"104","author":"Shore","year":"2013","journal-title":"Biophys J"},{"key":"10.1016\/j.bmc.2026.118819_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.apsb.2023.07.020","article-title":"Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain","volume":"14","author":"Zhu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2026.118819_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/164_2025_767","article-title":"Structural perspectives on biased allostery of GPCR Signaling","volume":"290","author":"Zhao","year":"2026","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bmc.2026.118819_bb0100","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1021\/acs.jcim.5c00884","article-title":"State-specific peptide design targeting G protein-coupled receptors","volume":"65","author":"Xue","year":"2025","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2026.118819_bb0105","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1038\/s41598-017-09808-8","article-title":"Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage","volume":"7","author":"Petrucci","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118819_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020453","article-title":"In silico prediction and validation of CB2 allosteric binding sites to aid the design of allosteric modulators","volume":"27","author":"Yuan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118819_bb0115","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1021\/acs.jmedchem.1c00561","article-title":"Design of Negative and Positive Allosteric Modulators of the cannabinoid CB2 receptor derived from the natural product cannabidiol","volume":"64","author":"Navarro","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118819_bb0120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65834","article-title":"Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2","volume":"11","author":"Raphael-Mizrahi","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.bmc.2026.118819_bb0125","doi-asserted-by":"crossref","first-page":"16766","DOI":"10.1021\/acs.jmedchem.5c01619","article-title":"Identification of an unexplored dynamic allosteric site on the activation pathway of the vasopressin V2 receptor","volume":"68","author":"Qiao","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118819_bb0130","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acs.jcim.0c00058","article-title":"Improving protein-peptide docking results via pose-clustering and rescoring with a combined knowledge-based and MM-GBSA scoring function","volume":"60","author":"Tao","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2026.118819_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-015-0567-3","article-title":"Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism","author":"Dalton","year":"2015","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.bmc.2026.118819_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107330","article-title":"Discovery and development of macrocyclic peptide modulators of the cannabinoid 2 receptor","volume":"300","author":"Toma\u0161evi\u0107","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118819_bb0145","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41401-024-01472-9","article-title":"Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery","volume":"46","author":"Shen","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bmc.2026.118819_bb0150","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1111\/bph.16502","article-title":"Allosterism in the adenosine A2A and cannabinoid CB2 heteromer","volume":"182","author":"Llinas Del Torrent","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2026.118819_bb0155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2020.01.007","article-title":"Cryo-EM structure of the human cannabinoid receptor CB2-Gi signaling complex","volume":"180","author":"Xing","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2026.118819_bb0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1021\/acsptsci.4c00547","article-title":"Identification of a cannabinoid receptor 2 allosteric site using computational modeling and pharmacological analysis","volume":"8","author":"Farooq","year":"2025","journal-title":"ACS Pharmacol Transl Sci"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:37:31Z","timestamp":1792067851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S0968089626002750"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118819","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the putative allosteric site J of cannabinoid receptor type 2 with peptide modulators: From mechanistic investigation to candidate identification","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118819"}}